Prevention of weight gain in type 2 diabetes requiring insulin treatment

Diabetes, Obesity and Metabolism

Volumn 6, Issue 2, 2004, Pages 114-119

  de Boer, H ^a   Jansen, M ^a   Koerts, J ^a   Verschoor, L ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Diabetes mellitus type 2; Insulin aspart; Insulin treatment; Rapid acting insulin analogues; Secondary failure; Weight gain glimepiride

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN ASPART; INSULIN DERIVATIVE; ISOPHANE INSULIN; LONG ACTING DRUG; METFORMIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; BODY FAT; BODY WEIGHT DISORDER; CHRONIC DISEASE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES CONTROL; DIET RESTRICTION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINISM; HYPOGLYCEMIA; MALE; MAXIMUM PERMISSIBLE DOSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; POSTPRANDIAL STATE; TREATMENT FAILURE; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 1242296095     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00322.x     Document Type: Article

References (22)

1. Mudaliar S, Edelman SV. Insulin therapy in type 2 diabetes. Endocrinol Metab Clin North Am 2001; 30 (4): 935-982.
2. DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus. JAMA 2003; 289: 2254-2264.
3. Yki-Yärvinen H. Combination therapies with insulin in type 2 diabetes. Diabetes Care 2001; 24: 758-767.
4. Mäkimattila S, Nikkilä K, Yki-Järvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with type II diabetes mellitus. Diabetologia 1999; 42: 406-412.
5. Groop L, Widén E, Franssila-Kallunki A et al. Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1989; 32: 599-605.
6. Rigalleau V, Delafaye C, Baillet L, Vergnot V, Brunou P, Gatta B, Gin H. Composition of insulin-induced body weight gain in diabetic patients: a bio-impedance study. Diabetes Metab 1999; 25: 321-328.
7. Bagg W, Plank LD, Gamble G, Drury PL, Sharpe N, Braatvedt GD. The effect of intensive glycaemic control on body composition in patients with type 2 diabetes. Diabetes Obes Metab 2001; 3: 410-416.
8. Sinha A, Formica C, Tsalamandris C et al. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes. Diabetes Med 1996; 13: 40-46.
9. Hoechst Marion Roussel. Scientific Monograph Amaryl®, 1995.
10. Rosenstock J, Samols E, Muchmore DB et al. Glimepiride, a new, once daily sulfonylurea: double-blind, placebo-controlled study of NIDDM patients. Diabetes Care 1996; 19: 1194-1199.
11. Sonnenberg GE, Garg DC, Weidler DJ et al. Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus. Ann Pharmacother 1997; 31: 671-676.
12. Buse J. Combining insulin and oral agents. Am J Med 2000; 108 (6A): 23S-32S.
13. Yki-Järvinen H, Ryysy L, Nikkilä K, Tulokas T, Vanamo R, Heikkilä M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. Ann Intern Med 1999; 130: 389-396.
14. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
15. Campbell PJ, Mandarino LJ, Gerich JE. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 1988; 37: 15-21.
16. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS. Intensive conventional insulin therapy for type II diabetes. Diabetes Care 1993; 16: 21-31.
17. Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH. Proinsulin, insulin and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 1975; 55: 1278-1283.
18. Song SH, McIntyre SS, Shah H, Veldhuis JD, Hayes PC, Butler PC. Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab 2000; 85: 4491-4499.
19. Anderson JH, Brunelle RL, Keohane P et al. Mealtime treatment with insulin analog improves hyperglycemia and hypoglycemia in patientes with non-insulin-dependent diabetes mellitus. Arch Intern Med 1997; 157: 1249-1255.
20. Feinglos MN, Thacker CH, English J et al. Modification of postprandial hyperglycemia with insulin Lispro improves glucose control in patients with type 2 diabetes. Diabetes Care 1997; 20: 1539-1542.
21. Rosenfalck AM, Thorsby P, Kjems L et al. Improved postprandial glycaemic control with insulin aspart in type 2 diabetic patients treated with insulin. Acta Diabetol 2000; 37: 41-46.
22. Garvey WT, Olefsky JM, Griffin J et al. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 1985; 34: 222-234.